eTheRNA -Model IV-cLP1 -LNP Platforms

SHARE

Therapeutic area: cancer vaccines; Systemic, intravenous (IV) administration

Most popular related searches
  • Allows preferential distribution to the spleen over the liver and other tissues
  • Maximizes T cell response and efficacy for systemic therapeutic vaccines
  • PreClinical validation with GLP safety and PK studies in NHP